Does Cabergoline help in decreasing endometrioma size compared to LHRH agonist? A prospective randomized study

Amr M Salaheldin Abdel Hamid, Wael A Ismail Madkour, Ashraf Moawad, Mohamed Abd Elzaher, Mary P Roberts, M. P. Roberts
Archives of gynecology and obstetrics · 2014 · vol. 290(4) , pp. 677–682 · doi:10.1007/s00404-014-3242-4 · PMID:24748338 · W2129779878
article OA: closed CC0 ⤵ 39 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06+body, 2026-06-09 ⓘ

This prospective randomized study compared Cabergoline and LHRH agonists for decreasing endometrioma size, finding Cabergoline more effective with fewer side effects.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosisendometrioma

MeSH descriptors

Dopamine Agonists Endometriosis Ergolines Genital Diseases, Female Luteolytic Agents Triptorelin Pamoate Administration, Oral Adult Cabergoline Dopamine Agonists Endometriosis Endometriosis Endometriosis Ergolines Female Genital Diseases, Female Genital Diseases, Female Genital Diseases, Female Gonadotropin-Releasing Hormone Gonadotropin-Releasing Hormone

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (31)

Cited by (39)

Source provenance

europepmc
last seen: 2026-06-20T06:14:18.781669+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:18:29.016410+00:00
License: CC0 · commercial use OK